[pending] METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)
Pending LLM rewrite. Source: FDA_DRUG D-0356-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Failed Dissolution Specifications
The recalled product
- Product
- METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)
- Brand
- METOPROLOL SUCCINATE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot#: a) 0718J251
- 0729J251
- 0730J251
- Exp.: 12/2026
- b) 0718J252
- 0729J252
- 0730J252
- Exp.: 12/2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL SUCCINATE
- ModerateMetoprolol Succinate Extended-Release Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2026-05-20
- HighMetoprolol Succinate Extended-Release Tablets Recalled for Storage Temperature Deviations
FDA (Drugs) · 2024-01-03
- HighMetoprolol Succinate ER Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2023-02-22
- HighPrescription Metoprolol Succinate Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2023-02-01
- ModerateMetoprolol Succinate Tablets Recalled for Failed Dissolution Specification
FDA (Drugs) · 2023-02-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27